We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AABA
401
DELISTED
Altaba Inc
AABA
$2.78M 0.04%
38,000
– –
L icon
402
Loews
L
$24.3B
$2.75M 0.04%
56,902
+23,571
+71% +$1.19M
MAS icon
403
Masco
MAS
$16B
$2.74M 0.04%
73,131
+9,889
+16% +$381K
NTLA icon
404
Intellia Therapeutics
NTLA
$1.5B
$2.73M 0.04%
99,700
+19,700
+25% +$477K
STZ icon
405
Constellation Brands
STZ
$22.2B
$2.71M 0.04%
12,404
-1,031
-8% -$233K
UGI icon
406
UGI
UGI
$8B
$2.71M 0.04%
52,123
-45,217
-46% -$2.19M
KGC icon
407
Kinross Gold
KGC
$28.5B
$2.68M 0.04%
712,740
-829,505
-54% -$3.12M
SJR
408
DELISTED
Shaw Communications Inc.
SJR
$2.68M 0.04%
131,739
-168,168
-56% -$3.43M
HRTX icon
409
Heron Therapeutics
HRTX
$86.3M
$2.68M 0.04%
+69,000
New +$2.2M
BOLD
410
DELISTED
Audentes Therapeutics, Inc
BOLD
$2.66M 0.04%
69,500
+11,500
+20% +$426K
AME icon
411
Ametek
AME
$55.5B
$2.65M 0.04%
36,713
-16,473
-31% -$1.22M
STAA icon
412
STAAR Surgical
STAA
$1.16B
$2.63M 0.04%
85,000
-28,000
-25% -$655K
MDGL icon
413
Madrigal Pharmaceuticals
MDGL
$12.6B
$2.63M 0.04%
+9,400
New +$1.65M
XRAY icon
414
Dentsply Sirona
XRAY
$2.59B
$2.62M 0.04%
59,796
-2,514
-4% -$118K
KR icon
415
Kroger
KR
$34.8B
$2.61M 0.04%
91,826
+18,446
+25% +$464K
FIS icon
416
Fidelity National Information Services
FIS
$21.5B
$2.6M 0.04%
24,498
-646
-3% -$65.7K
NOW icon
417
ServiceNow
NOW
$102B
$2.6M 0.04%
75,275
-2,540
-3% -$88K
PH icon
418
Parker-Hannifin
PH
$125B
$2.59M 0.04%
16,632
-4,312
-21% -$735K
EQIX icon
419
Equinix
EQIX
$107B
$2.58M 0.04%
5,992
+3
+0.1% +$1.21K
APH icon
420
Amphenol
APH
$188B
$2.54M 0.04%
116,704
+5,336
+5% +$116K
LUMN icon
421
Lumen
LUMN
$6.53B
$2.54M 0.04%
136,113
-64,856
-32% -$1.18M
FISV
422
Fiserv Inc
FISV
$27.2B
$2.54M 0.04%
34,205
-13,621
-28% -$989K
MTB icon
423
M&T Bank
MTB
$36.2B
$2.53M 0.04%
14,852
-678
-4% -$122K
ONCE
424
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.52M 0.04%
+30,400
New +$2.35M
HALO icon
425
Halozyme
HALO
$9.72B
$2.48M 0.04%
147,000
+25,000
+20% +$473K
15 16
17
18 19

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.